- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
53 Mantle Cell Lymphoma Trials Near You
Power is an online platform that helps thousands of Mantle Cell Lymphoma patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerZanubrutinib for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
421 Participants Needed
Trial Details
Key Eligibility Criteria
689 Participants Needed
Trial Details
Key Eligibility Criteria
28 Participants Needed
Trial Details
Key Eligibility Criteria
108 Participants Needed
Acalabrutinib + BR/VR for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
72 Participants Needed
Ibrutinib + Palbociclib for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
28 Participants Needed
Combination Therapy for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
373 Participants Needed
Chemotherapy Combinations for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
360 Participants Needed
Lenalidomide + Ibrutinib for Lymphoma
Trial Details
Key Eligibility Criteria
39 Participants Needed
Sonrotoclax + Zanubrutinib for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
300 Participants Needed
Oral LOXO-305 for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
860 Participants Needed
Palbociclib + Ibrutinib for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
39 Participants Needed
Zilovertamab Vedotin for Lymphoma
Trial Details
Key Eligibility Criteria
223 Participants Needed
TL-895 + Navtemadlin for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
130 Participants Needed
Cell Therapy for Non-Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
248 Participants Needed
Long-term Ibrutinib for Lymphoma
Trial Details
Key Eligibility Criteria
700 Participants Needed
Nivolumab + Lenalidomide for Lymphoma
Trial Details
Key Eligibility Criteria
36 Participants Needed
Lenalidomide + Blinatumomab for Lymphoma
Trial Details
Key Eligibility Criteria
44 Participants Needed
Nemtabrutinib for Blood Cancers
Trial Details
Key Eligibility Criteria
190 Participants Needed
Acalabrutinib + Pembrolizumab for Blood Cancers
Trial Details
Key Eligibility Criteria
161 Participants Needed
Why Other Patients Applied
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
Rituxan + Bendamustine + PCI-32765 for Lymphoma
Trial Details
Key Eligibility Criteria
48 Participants Needed
Gene Therapy for Acute Lymphoblastic Leukemia
Trial Details
Key Eligibility Criteria
32 Participants Needed
SGR-1505 for B-Cell Lymphoma
Trial Details
Key Eligibility Criteria
52 Participants Needed
LP-168 for Lymphoma
Trial Details
Key Eligibility Criteria
60 Participants Needed
ONM-501 + Cemiplimab for Cancer
Trial Details
Key Eligibility Criteria
168 Participants Needed
AC676 for B-Cell Malignancies
Trial Details
Key Eligibility Criteria
60 Participants Needed
Brexucabtagene Autoleucel for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
90 Participants Needed
LOXO-305 for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
500 Participants Needed
NX-2127 for B-cell Malignancies
Trial Details
Key Eligibility Criteria
248 Participants Needed
NX-5948 for B-cell Cancer
Trial Details
Key Eligibility Criteria
572 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Mantle Cell Lymphoma clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Mantle Cell Lymphoma clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Mantle Cell Lymphoma trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Mantle Cell Lymphoma is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Mantle Cell Lymphoma medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Mantle Cell Lymphoma clinical trials?
Most recently, we added Gene Therapy for Acute Lymphoblastic Leukemia, Sonrotoclax + Zanubrutinib for Mantle Cell Lymphoma and ATA3219 for Non-Hodgkin's Lymphoma to the Power online platform.